000 01176 a2200325 4500
005 20250514002601.0
264 0 _c20010830
008 200108s 0 0 ger d
022 _a0301-1526
024 7 _a10.1024/0301-1526.30.2.141
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFitzmaurice, D A
245 0 0 _a[Thromboembolism].
_h[electronic resource]
260 _bVASA. Zeitschrift fur Gefasskrankheiten
_cMay 2001
300 _a141-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHeparin
_xadministration & dosage
650 0 4 _aHeparin, Low-Molecular-Weight
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aPulmonary Embolism
_xdrug therapy
650 0 4 _aVenous Thrombosis
_xdrug therapy
700 1 _aHobbs, F D
773 0 _tVASA. Zeitschrift fur Gefasskrankheiten
_gvol. 30
_gno. 2
_gp. 141-5
856 4 0 _uhttps://doi.org/10.1024/0301-1526.30.2.141
_zAvailable from publisher's website
999 _c11347112
_d11347112